ARC Medical secures $3m for surgical adhesion clinical trials
The Canadian medical device company announced the completed financing on November 19, 2024.
ARC Medical announced a completed $3 million financing on November 19, 2024 to support clinical development of its liquid surgical adhesion barriers. The company did not identify the investors or financing instrument.
The funds were intended for a JOCOAT trial in knee surgery and an IPCOAT trial in gynecological surgery, as well as additional runway for discussions about a Japanese partnership. The announcement described planned studies rather than completed clinical results.
Based in Richmond, British Columbia, ARC develops liquids that form a temporary layer between tissues to reduce postoperative adhesions. JOCOAT targets orthopedic procedures; IPCOAT targets gynecological and abdominal procedures.
Use of funds
Support JOCOAT orthopedic clinical trial
Support IPCOAT gynecological clinical trial
Extend runway for Japanese partnership discussions